SG's June industrial production moderates, while AI-driven manufacturing momentum remains intact

June's softer industrial production print masks resilient underlying manufacturing momentum. With AI-driven semiconductor demand continuing to outpace supply, a multi-year capacity expansion underway, and broader economic indicators remaining firm, Singapore's manufacturing outlook remains constructive.

Adeline Gao Yuanhui
Adeline Gao Yuanhui31 Jul 2026 890 Views
SG's June industrial production moderates, while AI-driven manufacturing momentum remains intact

  • June industrial production growth moderated to 7.2% year-on-year following an exceptionally strong May, while the AI-driven manufacturing upcycle remained firmly intact.
  • Electronics and precision engineering continued to deliver double-digit growth, lifting first-half industrial production by 9.9%, or 14.0% excluding biomedical manufacturing.
  • Global memory shortages remain acute, with Micron's 2026 HBM supply already sold out and AI data centres consuming around 70% of global memory output.
  • Capacity expansion by UMC, Micron and VSMC between 2026 and 2028 provides a visible pipeline to support manufacturing growth well beyond this year.
  • We maintain our positive view on Singapore, supported by resilient manufacturing activity, record non-oil domestic exports, sustained PMI expansion, and stronger-than-expected second-quarter GDP growth.

Headline growth moderates, while technology-related manufacturing momentum remains robust

Singapore's manufacturing output rose 7.2% year on year in June 2026, easing from May's upwardly revised 17.8% increase and marking the slowest pace of expansion in three months. Excluding the inherently volatile biomedical manufacturing cluster, output grew a stronger 9.6%. On a seasonally adjusted month-on-month basis, industrial production declined 7.2%, partially reversing May's 6.9% increase after two consecutive months of exceptionally strong gains.

Table 1: Growth moderated from an exceptionally strong May base, while electronics and precision engineering remained key growth drivers

Industry Cluster

Apr-26

May-26

Jun-26

Cum 1H26

Electronics

31.3

49.2

21.3

29.2

Precision Engineering

15.7

30.5

14.9

13.5

Transport Engineering

10.8

-4.9

4.6

5.6

General Manufacturing

17.4

1.4

-6.8

2.2

Biomedical Manufacturing

-16.3

-24.7

-11.4

-20.8

Chemicals

-17.6

-11.4

-11.7

-9.6

Total Manufacturing Growth

12.8

17.8

7.2

9.9

Manufacturing Growth excl. Biomedical

16.2

23.2

9.6

14

Source: Singapore EDB, iFAST Compilations. Year-on-year growth (%).
Data as of 27 July 2026.

Technology-related manufacturing remained the primary growth driver. Electronics and precision engineering expanded 21.3% and 14.9% respectively, continuing to post double-digit growth despite a demanding comparison after electronics output surged 49.2% in May on strong AI server production.

By contrast, the weakness remained concentrated in the biomedical and chemicals clusters. Chemicals output declined 11.7% owing to feedstock supply disruptions in the petroleum and petrochemical segments, while biomedical manufacturing fell 11.4% because of changes in the mix of active pharmaceutical ingredients produced.

Electronics output continued to rise on a three-month moving-average basis, reinforcing the view that the AI-driven semiconductor upcycle remains intact despite month-to-month volatility. This is further supported by cumulative industrial production growth of 9.9% in the first half of 2026, or 14.0% excluding biomedical manufacturing, well above the sector's historical trend. Against this backdrop, June's softer headline appears to reflect normalisation following an exceptionally strong May, rather than a deterioration in underlying manufacturing momentum.

Demand continues to outpace supply, supporting a constructive outlook

More importantly, the moderation in June's industrial production does not reflect weaker demand. Singapore's manufacturing sector remains heavily concentrated in memory chips and integrated circuits—segments that continue to face acute global supply shortages amid the AI infrastructure build-out. According to TrendForce, conventional DRAM contract prices rose 58% to 63% quarter-on-quarter in the second quarter of 2026, while NAND prices increased 70% to 75% as manufacturers redirected production capacity towards high-bandwidth memory (HBM) for AI servers. Micron has already sold out its entire HBM supply for 2026, while SK Hynix's chief executive stated in July that supply shortages could persist beyond 2030, with AI data centres now consuming an estimated 70% of global memory output. Taken together, these developments suggest that production capacity is currently a greater constraint on manufacturing output than underlying demand.

Fortunately, additional capacity is beginning to come online. UMC's new 22nm fabrication plant entered volume production in 2026, lifting Singapore's annual wafer manufacturing capacity to more than one million, while Micron's HBM advanced packaging facility is also ramping up production this year. Looking further ahead, VSMC's USD 7.8 billion 300mm wafer fabrication plant is scheduled to commence production in 2027 before scaling to 55,000 wafers per month by 2029. Micron's USD 24 billion NAND fabrication facility is also expected to begin wafer production in the second half of 2028. Together, these investments provide a visible pipeline of capacity expansion that should support Singapore's manufacturing output well beyond 2026.

The broader macroeconomic outlook remains supportive. In its July monetary policy statement, the Monetary Authority of Singapore (MAS) said the economy is expected to continue expanding at a firm pace in the second half of 2026, supported by sustained global AI-related capital expenditure and resilient activity across technology-related industries. While the Economic Development Board has maintained its 2026 industrial production growth forecast at 4%, the strong performance in the first half of the year raises the likelihood of an upward revision should manufacturing momentum remain firm over the coming months.

The principal risk to this outlook stems from the sector's increasing reliance on electronics. A sharper-than-expected slowdown in global AI infrastructure investment would weigh directly on Singapore's manufacturing output, while continued weakness in the inherently volatile biomedical and chemicals clusters could remain a drag on headline industrial production during the second half of the year.

Positive view on Singapore maintained

June's moderation in industrial production does not materially change our assessment of Singapore's manufacturing outlook. Together with record non-oil domestic exports, an eleventh consecutive month of manufacturing PMI expansion, and stronger-than-expected second-quarter GDP growth, the latest data continue to point to an economy supported by structural demand rather than a short-lived cyclical rebound.

Related articles: Singapore’s NODX continues to expand, further solidifying its economic resilience

AI demand continues to confirm our case for Singapore equities

Confirmed but contained: Singapore's 12.5% US tariff takes effect, thesis intact

We therefore maintain our positive view on Singapore. For investors seeking diversified exposure to Singapore equities, we continue to recommend positioning through the Amova Singapore STI ETF (SGX: G3B) for broad, low-cost exposure, and the iFAST-Amova Singapore Equity A SGD for investors seeking higher SMID-cap exposure beyond the STI 30 blue chips.


Declaration

For specific disclosure, at the time of publication of this report, IFPL (via its connected and associated entities) and the analyst who produced this report hold a NIL position in the abovementioned securities.

This research report was prepared with the assistance of artificial intelligence (AI) tools. iFAST Financial Pte Ltd does not rely exclusively on AI for content generation; the content of this report, including all investment theses, ratings, price targets and conclusions, has been independently reviewed and verified by the research analyst(s) to ensure accuracy and professional integrity.

All materials and contents found in this site are strictly for general circulation and informational purposes only and should not be considered as an offer, or solicitation, to deal in any of the funds or products found/identified in this site. While iFAST Financial Pte Ltd ("IFPL") has tried to provide accurate and timely information, there may be inadvertent delays, omissions, technical or factual inaccuracies and typographical errors. Any opinion or estimate contained in this report is made on a general basis and neither IFPL nor any of its servants or agents have given any consideration to nor have they or any of them made any investigation of the investment objective, financial situation or particular need of any user or reader, any specific person or group of persons. You should consider carefully if the products you are going to purchase are suitable for your investment objective, investment experience, risk tolerance and other personal circumstances. If you are uncertain about the suitability of the investment product, please seek advice from a financial adviser, before making a decision to purchase the investment product. Past performance is not indicative of future performance. The value of the investment products and the income from them may fall as well as rise. Opinions expressed herein are subject to change without notice. In respect of any matters arising from, or in connection with the said research analyses or research reports, recipients of the report are to contact IFPL at 10 Collyer Quay, #26-01 Ocean Financial Centre Building, Singapore 049315, or by telephone at +65 6557 2853. Where the report contains research analyses or research reports from a foreign research house and if the recipient of such research analyses or research reports is not an accredited investor, expert investor, institutional investor or an ex-accredited investor, IFPL accepts legal responsibility for the contents of such analyses or reports to such persons only to the extent as required by law. Please note that only certain security(ies) herein are available to all investors, while the rest are only available for certain persons to invest in, such as Accredited Investors (as defined in the Securities and Futures Act) or one who invests at least S$200,000 (or its equivalent currency) per transaction. To qualify as an Accredited Investor, one needs to submit a declaration form and certain relevant supporting documents, according to iFAST’s prevailing policies and procedures.

Please read our full disclaimers on the website at ( https://fsm.global/sg/policies/328125/investment-account-terms-&-conditions).

iFAST Financial Pte Ltd (IFPL) (registered address: 10 Collyer Quay #26-01 Ocean Financial Centre Singapore 049315, Telephone: 6557 2000) holds the Financial Advisers Licence issued by the Monetary Authority of Singapore ('MAS') to conduct regulated activities of advising on securities, marketing of collective investment schemes and arranging of any contract of insurance in respect of life policies, other than a contract of reinsurance and the Capital Markets Services Licence issued by the MAS to conduct regulated activities of dealing in securities and providing custodial services for securities. While IFPL has made every effort to ensure the independence of the report's contents, IFPL's nature of business is such that IFPL and its connected and associated entities together with their respective directors, officers and staff may be involved in providing dealing or investment-related services in the abovementioned securities, and have taken or may take positions in the securities mentioned in this report, and may also act as the principal for any buy or sell trades.